STOCK TITAN

James Pursley to sell 15,000 HNGE shares (HNGE) under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

James Pursley reported a planned sale of 15,000 common shares of HNGE under a 10b5-1 arrangement. The filing shows the sale date 12/22/2025 and a gross sale amount of $725,950.50. The shares trace to Performance Stock Units dated 04/01/2023.

Positive

  • None.

Negative

  • None.

Insights

Insider sale recorded under a 10b5-1 plan: routine disclosure of a planned disposition.

The filing lists a 10b5-1 sale by James Pursley of 15,000 common shares with a reported gross amount of $725,950.50 on 12/22/2025. The shares are linked to Performance Stock Units dated 04/01/2023.

Such filings are typically administrative and depend on plan terms; cash-flow treatment and any lockups are not shown in the excerpt. Subsequent public filings would show actual transaction settlement details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did HNGE insider James Pursley disclose in the Form 144?

The filing discloses a planned sale of 15,000 common shares by James Pursley under a 10b5-1 plan. The reported sale date is 12/22/2025 with a gross amount of $725,950.50.

Are the sold shares for HNGE from stock awards or open‑market holdings?

The disclosure ties the shares to Performance Stock Units dated 04/01/2023. The filing indicates the securities originate from those award units rather than an unspecified open‑market holding.

How much cash is reported from the planned HNGE sale?

The Form 144 shows a reported gross sale amount of $725,950.50. The excerpt does not break out net proceeds, taxes withheld, or settlement details beyond that gross figure.

When was the HNGE sale scheduled to occur per the filing?

The filing lists the sale date as 12/22/2025 under a 10b5-1 sales plan. The excerpt provides that specific date for the planned disposition.

Does the Form 144 show any trading restrictions or lockups for these HNGE shares?

The provided excerpt does not include language about trading restrictions or lockups. It lists the security type and award date but does not specify post‑award restrictions or holding periods.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.03B
34.52M
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO